Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...

CEO Bill Sibold hailed 2024 as a "transformational year" for Madrigal Pharmaceuticals, but Wall Street isn't as enthusiastic about the company's sales results.

Citi analyst David Lebowitz has maintained their bullish stance on MDGL stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Hold rating on Madrigal Pharmaceuticals (MDGL – Research ...

The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units, as noted ...

Army Ranger, who lied about contacting the Russian Embassy, was also indicted for cyberstalking an ex-girlfriend.

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

根据提交给美国证券交易委员会的Form 4文件显示，Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)的总法律顾问Kelley Shannon ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)研发总裁兼首席医疗官Rebecca Taub最近出售了1,689股公司普通股。这些股票以平均每股273.41美元的价格售出，交易总额约为461,789美元。根据 InvestingPro 的数据，该公司股票目前交易价格为293.64美元，过去一周下跌了13.36%。尽管近期波动，分析师仍保持看好态度，给予"买入 ...

Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers." ...